Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities

Early responses to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)-chronic phase (CP) are associated with improved outcome. We analyzed the impact of such a response on outcomes among patients treated with 4 TKI modalities as frontline therapy in CML-CP. A total of 483 patients w...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Jain, Preetesh, Kantarjian, Hagop, Nazha, Aziz, O’Brien, Susan, Jabbour, Elias, Romo, Carlos Guillermo, Pierce, Sherry, Cardenas-Turanzas, Marylou, Verstovsek, Srdan, Borthakur, Gautam, Ravandi, Farhad, Quintás-Cardama, Alfonso, Cortes, Jorge
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2013
נושאים:
Clinical Trials and Observations
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3743466/
https://ncbi.nlm.nih.gov/pubmed/23620574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-490128
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים